CA Stock MarketDetailed Quotes
MGRO MustGrow Biologics Corp
- 0.750
- +0.010+1.35%
15min DelayMarket Closed Jun 28 16:00 ET
38.70MMarket Cap-75000P/E (TTM)
0.750High0.700Low9.50KVolume0.700Open0.740Pre Close6.97KTurnover1.99052wk High0.02%Turnover Ratio51.60MShares0.67052wk Low-0.01EPS TTM33.92MFloat Cap5.600Historical HighLossP/E (Static)45.22MShs Float0.250Historical Low-0.01EPS LYR6.76%Amplitude--Dividend TTM8.24P/B1Lot Size--Div YieldTTM
MustGrow Biologics Corp Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2.08%-931.37K | 90.95%-294.76K | 385.74%2.65M | -16.20%-912.39K | -35.07%-3.26M | -927.57K | -13.57%-560.51K | -63.04%-984.28K | -36.45%-785.19K | 6.48%-2.41M |
| Net income from continuing operations | 1.14%-1.03M | 87.84%-676.94K | 442.48%3.43M | -3.64%-1.05M | -81.66%-5.57M | ---1M | -206.41%-2.13M | -115.39%-1.42M | -64.91%-1.01M | 7.43%-3.06M |
| Remuneration paid in stock | 19.10%144.15K | -45.33%926.42K | -240.64%-290.6K | -41.62%121.03K | 525.73%1.69M | --206.62K | 884.22%1.11M | 311.77%173.65K | 246.66%207.33K | -65.14%270.81K |
| Other non cashItems | ---- | ---- | ---- | ---- | -80.92%10.07K | --0 | -2,059.66%-264.93K | 1,859.66%264.93K | -17.55%10.07K | 15.03%52.77K |
| Change In working capital | -415.44%-41K | -190.15%-544.24K | -269.62%-489.62K | 83.68%13K | 83.76%603.7K | ---132.47K | 853.67%730.43K | -332.64%-1.34K | 120.11%7.08K | 2,329.53%328.52K |
| -Change in receivables | -831.37%-29.42K | 70.11%-7.02K | -85.52%3.9K | -66.41%4.02K | 24.28%-23.49K | --26.94K | -3,519.50%-64.53K | 158.66%2.12K | -31.11%11.98K | -138.73%-31.03K |
| -Change in prepaid assets | 107.64%7.88K | 135.57%4.53K | 2,127.18%46.21K | -621.59%-103.12K | -253.37%-12.73K | --2.08K | 10.06%29.61K | -176.93%-30.13K | 75.66%-14.29K | 145.09%8.3K |
| -Change in payables and accrued expense | -117.35%-19.45K | 136.32%99.45K | 162.84%101.47K | 1,093.53%112.1K | -177.95%-273.78K | ---161.48K | -410.39%-148.36K | 176.26%26.66K | 52.72%9.39K | 681.90%351.25K |
| -Change in other working capital | ---- | -170.18%-641.2K | ---- | ---- | --913.7K | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2.08%-931.37K | 90.95%-294.76K | 385.74%2.65M | -16.20%-912.39K | -35.07%-3.26M | ---927.57K | -13.57%-560.51K | -63.04%-984.28K | -36.45%-785.19K | 6.48%-2.41M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -85.35%95.75K | 0 | -92.50%653.75K | 0 | -57.94%157.5K | 0 | -52.11%496.25K | 368.05%8.72M | ||
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6.59M |
| Proceeds from stock option exercised by employees | ---- | -85.35%95.75K | --0 | ---- | -69.35%653.75K | --0 | -57.94%157.5K | --0 | -52.11%496.25K | 16.76%2.13M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | -85.35%95.75K | --0 | ---- | -92.50%653.75K | --0 | -57.94%157.5K | --0 | -52.11%496.25K | 368.05%8.72M |
| Net cash flow | ||||||||||
| Beginning cash position | -2.84%6.82M | -27.07%7.02M | -47.55%4.17M | -27.07%7.02M | 190.39%9.62M | --7.94M | 161.93%8.35M | 147.27%9.33M | 190.39%9.62M | -17.77%3.31M |
| Current changes in cash | -2.08%-931.37K | 92.36%-199.01K | 385.74%2.65M | -215.77%-912.39K | -141.28%-2.6M | ---927.57K | -238.37%-403.01K | -67.65%-984.28K | -162.69%-288.94K | 980.87%6.31M |
| End cash Position | -3.57%5.89M | -2.84%6.82M | -2.84%6.82M | -34.59%6.1M | -27.07%7.02M | --7.02M | 158.97%7.94M | 161.93%8.35M | 147.27%9.33M | 190.39%9.62M |
| Free cash from | -2.08%-931.37K | 90.95%-294.76K | 385.74%2.65M | -16.20%-912.39K | -35.07%-3.26M | ---927.57K | -13.57%-560.51K | -63.04%-984.28K | -36.45%-785.19K | 6.48%-2.41M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg